NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
11.11
-0.47 (-4.06%)
The current stock price of ARDT is 11.11 USD. In the past month the price decreased by -14.27%. In the past year, price decreased by -35.78%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 15.95 | 86.87B | ||
THC | TENET HEALTHCARE CORP | 13.42 | 16.26B | ||
EHC | ENCOMPASS HEALTH CORP | 23.51 | 11.11B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 9.5 | 10.89B | ||
ENSG | ENSIGN GROUP INC/THE | 23.92 | 7.86B | ||
SGRY | SURGERY PARTNERS INC | 25.36 | 2.86B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 14.38 | 2.51B | ||
ACHC | ACADIA HEALTHCARE CO INC | 7.66 | 2.02B | ||
PACS | PACS GROUP INC | 15.74 | 1.86B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 10.73 | 1.85B | ||
BKD | BROOKDALE SENIOR LIVING INC | N/A | 1.81B | ||
NHC | NATIONAL HEALTHCARE CORP | 14.1 | 1.51B |
Ardent Health Partners, Inc. engages in the provision of healthcare and related services. The company is headquartered in Brentwood, Tennessee and currently employs 19,200 full-time employees. The company went IPO on 2024-07-18. The firm operates in eight mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The company provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a broad network of ambulatory facilities and telehealth services, including 146 primary care and specialty care clinics, three ambulatory surgery centers (ASCs), 40 urgent care centers, two freestanding emergency departments, and ten diagnostic imaging centers. The firm also operates a consumer-centric healthcare platform focused on creating long-lasting relationships with its patients across multiple care settings.
ARDENT HEALTH INC
340 Seven Springs Way, Suite 100
Brentwood TENNESSEE US
Employees: 19200
Phone: 16152963000
The current stock price of ARDT is 11.11 USD. The price decreased by -4.06% in the last trading session.
The exchange symbol of ARDENT HEALTH INC is ARDT and it is listed on the New York Stock Exchange, Inc. exchange.
ARDT stock is listed on the New York Stock Exchange, Inc. exchange.
17 analysts have analysed ARDT and the average price target is 20.87 USD. This implies a price increase of 87.84% is expected in the next year compared to the current price of 11.11. Check the ARDENT HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ARDENT HEALTH INC (ARDT) has a market capitalization of 1.59B USD. This makes ARDT a Small Cap stock.
ARDENT HEALTH INC (ARDT) currently has 19200 employees.
ARDENT HEALTH INC (ARDT) has a resistance level at 13.25. Check the full technical report for a detailed analysis of ARDT support and resistance levels.
The Revenue of ARDENT HEALTH INC (ARDT) is expected to grow by 8.36% in the next year. Check the estimates tab for more information on the ARDT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ARDT does not pay a dividend.
ARDENT HEALTH INC (ARDT) will report earnings on 2025-08-13.
The PE ratio for ARDENT HEALTH INC (ARDT) is 6.9. This is based on the reported non-GAAP earnings per share of 1.61 and the current share price of 11.11 USD. Check the full fundamental report for a full analysis of the valuation metrics for ARDT.
The outstanding short interest for ARDENT HEALTH INC (ARDT) is 1.52% of its float. Check the ownership tab for more information on the ARDT short interest.
ChartMill assigns a fundamental rating of 5 / 10 to ARDT. ARDT has an average financial health and profitability rating.
Over the last trailing twelve months ARDT reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS increased by 314.38% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.73% | ||
ROA | 4.57% | ||
ROE | 19.12% | ||
Debt/Equity | 0.93 |
ChartMill assigns a Buy % Consensus number of 82% to ARDT. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of 58.8% and a revenue growth 8.36% for ARDT